Range Cancer Therapeutics ETF (CNCR)
NASDAQ: CNCR · IEX Real-Time Price · USD
13.10
0.00 (0.00%)
At close: Jul 3, 2024, 12:59 PM
13.17
+0.06 (0.50%)
After-hours: Jul 3, 2024, 1:15 PM EDT
CNCR Holdings List
As of Jun 27, 2024
| No. | Symbol | Name | % Weight |
|---|---|---|---|
| 1 | GERN | Geron Corporation | 3.93% |
| 2 | ELVN | Enliven Therapeutics, Inc. | 3.15% |
| 3 | SMMT | Summit Therapeutics Inc. | 2.57% |
| 4 | NRIX | Nurix Therapeutics, Inc. | 2.29% |
| 5 | ITOS | iTeos Therapeutics, Inc. | 2.24% |
| 6 | NUVB | Nuvation Bio Inc. | 2.15% |
| 7 | MRUS | Merus N.V. | 2.09% |
| 8 | IBRX | ImmunityBio, Inc. | 2.07% |
| 9 | BPMC | Blueprint Medicines Corporation | 1.92% |
| 10 | RVMD | Revolution Medicines, Inc. | 1.87% |
| 11 | AGEN | Agenus Inc. | 1.83% |
| 12 | ACRV | Acrivon Therapeutics, Inc. | 1.76% |
| 13 | ERAS | Erasca, Inc. | 1.72% |
| 14 | REGN | Regeneron Pharmaceuticals, Inc. | 1.70% |
| 15 | MRK | Merck & Co., Inc. | 1.67% |
| 16 | JANX | Janux Therapeutics, Inc. | 1.66% |
| 17 | PGEN | Precigen, Inc. | 1.64% |
| 18 | HCM | HUTCHMED (China) Limited | 1.61% |
| 19 | CGEM | Cullinan Oncology, Inc. | 1.57% |
| 20 | EXEL | Exelixis, Inc. | 1.55% |
| 21 | IMTX | Immatics N.V. | 1.52% |
| 22 | AURA | Aura Biosciences, Inc. | 1.51% |
| 23 | DAWN | Day One Biopharmaceuticals, Inc. | 1.51% |
| 24 | REPL | Replimune Group, Inc. | 1.49% |
| 25 | TSVT | 2seventy bio, Inc. | 1.47% |
| 26 | FHTX | Foghorn Therapeutics Inc. | 1.47% |
| 27 | TNGX | Tango Therapeutics, Inc. | 1.46% |
| 28 | KURA | Kura Oncology, Inc. | 1.45% |
| 29 | NUVL | Nuvalent, Inc. | 1.41% |
| 30 | SNDX | Syndax Pharmaceuticals, Inc. | 1.39% |
| 31 | BCYC | Bicycle Therapeutics plc | 1.37% |
| 32 | XNCR | Xencor, Inc. | 1.35% |
| 33 | TYRA | Tyra Biosciences, Inc. | 1.35% |
| 34 | BNTX | BioNTech SE | 1.34% |
| 35 | GMAB | Genmab A/S | 1.31% |
| 36 | RCUS | Arcus Biosciences, Inc. | 1.28% |
| 37 | PRLD | Prelude Therapeutics Incorporated | 1.28% |
| 38 | YMAB | Y-mAbs Therapeutics, Inc. | 1.27% |
| 39 | BMY | Bristol-Myers Squibb Company | 1.23% |
| 40 | EXAI | Exscientia plc | 1.22% |
| 41 | IPHA | Innate Pharma S.A. | 1.21% |
| 42 | ZYME | Zymeworks Inc. | 1.21% |
| 43 | ACLX | Arcellx, Inc. | 1.21% |
| 44 | RLAY | Relay Therapeutics, Inc. | 1.20% |
| 45 | IDYA | IDEAYA Biosciences, Inc. | 1.19% |
| 46 | KYMR | Kymera Therapeutics, Inc. | 1.19% |
| 47 | SWTX | SpringWorks Therapeutics, Inc. | 1.18% |
| 48 | SDGR | Schrödinger, Inc. | 1.17% |
| 49 | STRO | Sutro Biopharma, Inc. | 1.13% |
| 50 | KPTI | Karyopharm Therapeutics Inc. | 1.13% |
As of Jun 27, 2024